Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125715121 | 12571512 | 1 | I | 20160228 | 20160711 | 20160719 | 20160719 | EXP | CN-SA-2016SA129434 | AVENTIS | 44.00 | YR | A | M | Y | 74.00000 | KG | 20160719 | OT | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125715121 | 12571512 | 1 | PS | ELOXATIN | OXALIPLATIN | 1 | Intravenous drip | DAY 1 | U | 14F02 | 21759 | 200 | MG | POWDER FOR INJECTION | /cycle | ||||
| 125715121 | 12571512 | 2 | SS | GEMZAR | GEMCITABINE HYDROCHLORIDE | 1 | Unknown | 1.4 D1, 8 | U | C451533A | 0 | 1.4 | G | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125715121 | 12571512 | 1 | Chemotherapy |
| 125715121 | 12571512 | 2 | Chemotherapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125715121 | 12571512 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125715121 | 12571512 | Bone marrow failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125715121 | 12571512 | 1 | 20160219 | 20160219 | 0 | |
| 125715121 | 12571512 | 2 | 20160219 | 20160226 | 0 |